These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23095131)

  • 1. A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition.
    Masola V; Onisto M; Zaza G; Lupo A; Gambaro G
    J Transl Med; 2012 Oct; 10():213. PubMed ID: 23095131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells.
    Masola V; Gambaro G; Tibaldi E; Brunati AM; Gastaldello A; D'Angelo A; Onisto M; Lupo A
    J Biol Chem; 2012 Jan; 287(2):1478-88. PubMed ID: 22102278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity.
    Masola V; Zaza G; Secchi MF; Gambaro G; Lupo A; Onisto M
    Biochim Biophys Acta; 2014 Sep; 1843(9):2122-8. PubMed ID: 24937189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight fucoidan and its fractions inhibit renal epithelial mesenchymal transition induced by TGF-β1 or FGF-2.
    Li X; Li X; Zhang Q; Zhao T
    Int J Biol Macromol; 2017 Dec; 105(Pt 2):1482-1490. PubMed ID: 28627391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase.
    Masola V; Zaza G; Granata S; Gambaro G; Onisto M; Lupo A
    J Transl Med; 2013 Nov; 11():292. PubMed ID: 24256696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells.
    Masola V; Gambaro G; Tibaldi E; Onisto M; Abaterusso C; Lupo A
    Biochim Biophys Acta; 2011 Aug; 1813(8):1475-82. PubMed ID: 21600934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
    Kang MK; Park SH; Choi YJ; Shin D; Kang YH
    J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of heparanase on renal fibrosis.
    Masola V; Zaza G; Onisto M; Lupo A; Gambaro G
    J Transl Med; 2015 Jun; 13():181. PubMed ID: 26040666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
    Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
    Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation.
    Strutz F; Zeisberg M; Ziyadeh FN; Yang CQ; Kalluri R; Müller GA; Neilson EG
    Kidney Int; 2002 May; 61(5):1714-28. PubMed ID: 11967021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulodexide and glycosaminoglycans in the progression of renal disease.
    Masola V; Zaza G; Gambaro G
    Nephrol Dial Transplant; 2014 Feb; 29 Suppl 1():i74-i79. PubMed ID: 24493873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
    Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
    Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice.
    Yang G; Zhao Z; Zhang X; Wu A; Huang Y; Miao Y; Yang M
    Drug Des Devel Ther; 2017; 11():1065-1079. PubMed ID: 28408805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with streptozotocin-induced type I diabetic nephropathy.
    Yung S; Chau MK; Zhang Q; Zhang CZ; Chan TM
    PLoS One; 2013; 8(1):e54501. PubMed ID: 23349910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545.
    Abassi Z; Hamoud S; Hassan A; Khamaysi I; Nativ O; Heyman SN; Muhammad RS; Ilan N; Singh P; Hammond E; Zaza G; Lupo A; Onisto M; Bellin G; Masola V; Vlodavsky I; Gambaro G
    Oncotarget; 2017 May; 8(21):34191-34204. PubMed ID: 28388547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of sulodexide on podocyte injury in adriamycin nephropathy rats.
    Chen S; Fang Z; Zhu Z; Deng A; Liu J; Zhang C
    J Huazhong Univ Sci Technolog Med Sci; 2009 Dec; 29(6):715-9. PubMed ID: 20037813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy.
    Lu Q; Chen YB; Yang H; Wang WW; Li CC; Wang L; Wang J; Du L; Yin XX
    Acta Pharmacol Sin; 2019 Dec; 40(12):1555-1567. PubMed ID: 31235817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulodexide Protects Renal Tubular Epithelial Cells from Oxidative Stress-Induced Injury via Upregulating Klotho Expression at an Early Stage of Diabetic Kidney Disease.
    Liu YN; Zhou J; Li T; Wu J; Xie SH; Liu HF; Liu Z; Park TS; Wang Y; Liu WJ
    J Diabetes Res; 2017; 2017():4989847. PubMed ID: 28929120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of heparanase in diseases of the glomeruli.
    Szymczak M; Kuźniar J; Klinger M
    Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):45-56. PubMed ID: 20049646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin.
    Lewis EJ; Xu X
    Diabetes Care; 2008 Feb; 31 Suppl 2():S202-7. PubMed ID: 18227486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.